Gastrointestinal tumours, melanoma
Conditions
Interventions
Case group (irAEs group):None
Control group (non-irAEs group):None
Sponsors
Shanghai Tenth People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Age 18 or above, gender is not limited 2. Completed at least 1 cycle of ICI treatment 3. histopathologically diagnosed with advanced solid tumour 4. have complete baseline data (e.g. age, gender, past medical history, treatment regimen, occurrence of irAEs) 5. Follow-up time = 3 months
Exclusion criteria
Exclusion criteria: 1. Previous severe autoimmune or other diseases (e.g., systemic lupus erythematosus, myasthenia gravis, severe lesions of other organs) 2. Use of immunosuppressants or glucocorticoids within 3 months prior to ICI treatment 3. Lack of critical clinical data (e.g., lack of baseline data, inadequate follow-up time)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Immune-related adverse events; | — |
Secondary
| Measure | Time frame |
|---|---|
| Progression-free survival; | — |
Countries
China
Contacts
Public ContactZhuqing Liu
Shanghai Tenth People's Hospital
Outcome results
None listed